REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorios Eurofarma Bolivia S.A. (Bolivia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Laboratorios Eurofarma Bolivia S.A. Profile Updated: March 26, 2026
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Laboratorios Eurofarma Bolivia S.A. is a company in Bolivia, with a head office in Andres Ibanez. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on April 03, 2026. 3 (estimated) employees currently work for Laboratorios Eurofarma Bolivia S.A.. In its most recent financial highlights, the company reported a net sales revenue increase of 13.53% in 2022. Over the same period, its total assets grew by 15.13%. The net profit margin of Laboratorios Eurofarma Bolivia S.A. decreased by 5.95% in 2022.

Headquarters
Avenida Cuarto Anillo, #4200, Barrio Equipetrol, Norte, Edificio Torre Duo Centrol Empresarial
Andres Ibanez; Santa Cruz;

Contact Details: Purchase the Laboratorios Eurofarma Bolivia S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorios Eurofarma Bolivia S.A. report to view the information.
Financial Auditors:
Purchase the Laboratorios Eurofarma Bolivia S.A. report to view the information.
Incorporation Date:
April 03, 2026
Key Executives
Purchase this report to view the information.
Trustee
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorios Eurofarma Bolivia S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BOB. Absolute financial data is included in the purchased report.
Net sales revenue
13.53%
Total Operating Revenue
13.53%
Operating Profit
-11.42%
EBITDA
-11.42%
Net Profit/Loss for the Period
-16.03%
Total Assets
15.13%
Total Equity
20.42%
Operating Profit Margin
-6.38%
Net Profit Margin
-5.95%
Return on Equity (ROE)
-7.35%
Quick Ratio
1.05%
Cash Ratio
0.79%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?